These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9085149)

  • 41. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histological analysis of intraepidermal proliferations of atypical melanocytes.
    Urso C; Giannini A; Bartolini M; Bondi R
    Am J Dermatopathol; 1990 Apr; 12(2):150-5. PubMed ID: 2331049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL; King LE; Nanney LB
    J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melanocytic Nevus With Elastophilic Features.
    Tran TAN
    Am J Dermatopathol; 2022 Sep; 44(9):677-679. PubMed ID: 35503877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between melanocytes and peripheral nerve sheath cells (Part I): melanocytic nevus (excluding so-called "blue nevus") with peripheral nerve sheath differentiation.
    Misago N
    Am J Dermatopathol; 2000 Jun; 22(3):217-29. PubMed ID: 10871064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP; Smart C; Cassarino DS
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
    Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
    Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW
    J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of gamma-H2AX in melanocytic lesions.
    Wasco MJ; Pu RT; Yu L; Su L; Ma L
    Hum Pathol; 2008 Nov; 39(11):1614-20. PubMed ID: 18656236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
    Rhodes AR; Melski JW; Sober AJ; Harrist TJ; Mihm MC; Fitzpatrick TB
    J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IMP-3 expression in melanocytic lesions.
    Yu L; Xu H; Wasco MJ; Bourne PA; Ma L
    J Cutan Pathol; 2010 Mar; 37(3):316-22. PubMed ID: 19788446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nevi, other than dysplastic and Spitz nevi.
    Cochran AJ; Bailly C; Paul E; Dolbeau D
    Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
    Smoller BR; McNutt NS; Hsu A
    Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Compound blue nevus": a reappraisal of "superficial blue nevus with prominent intraepidermal dendritic melanocytes" with emphasis on dermoscopic and histopathologic features.
    Ferrara G; Argenziano G; Zgavec B; Bartenjev I; Staibano S; De Rosa G; Soyer HP
    J Am Acad Dermatol; 2002 Jan; 46(1):85-9. PubMed ID: 11756951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological and prognostic relevance of Rap1-GAP expression in melanocytic tumors.
    Weiss J; Biwer B; Schliz M; Jung EG
    Arch Dermatol Res; 1997 Sep; 289(10):573-7. PubMed ID: 9373716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of intermedial filament nestin in malignant melanoma progression].
    Brychtová S; Fiurásková M; Brychta T; Hirnák J
    Cesk Patol; 2005 Oct; 41(4):143-5. PubMed ID: 16382989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT; van Belle P; Elenitsas R; Elder DE
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.